Omar Abdallah
Senior Vice President, Product Development
Omar Abdallah is a bioengineer and entrepreneur, serving as the Founder and CEO of Biogyptech, Inc., where he develops medical devices and IVD platforms. He also leads systems engineering and business development at AmplifiDx, Inc., focusing on molecular point-of-care diagnostics. With a background in quality and regulatory affairs, Omar has a successful track record in managing teams and projects. Read More
Srilekha Deka, PhD
Senior Vice President, Regulatory Affairs
Dr. Srilekha Deka is a seasoned biotechnology professional with extensive experience in commercializing molecular diagnostic assays. A proactive leader, she excels in managing projects from initiation to completion, particularly in the development of infectious disease assays across various qPCR platforms. Read More
Nancy Schoenbrunner, PhD
Product & Business Strategy
Dr. Nancy Schoenbrunner is an accomplished executive in molecular diagnostics with over 20 years of experience, including her time at Roche Diagnostics and start-ups like Nanogenecs Diagnostics and Scipher Medicine. She has successfully led the launch of major diagnostic products, such as the Cobas® EGFR cancer test and Cobas® 6800/8800 system. Read More
Laura Gillis, PhD
Biostatistics Lead
Dr. Laura Gillis is a biostatistician with a PhD in statistics and over 30 years of experience. She specializes in clinical trial design, analytical assay validation, and predictive modeling. Renowned for her leadership, she effectively manages teams to deliver tailored analyses. With strong communication skills, Laura simplifies complex statistical findings for diverse audiences. Proficient in SAS, R, and SPSS, she is a leading expert in biostatistics and medical research.
Neil Mucci
Clinical Operations
Neil Mucci is the founder and CEO of Global BioClinical, a Seattle-based consulting and clinical research organization specializing in biospecimen services and diagnostic medical device testing. With a strong background in clinical trial management, he previously served as Head of Clinical Study Management at Epigenomics AG, overseeing studies with over 10,000 participants for a colorectal cancer diagnostic test. Read More
Dave Mock, MBA
Vice President, Quality Assurance
Dave Mock is a medical device and life sciences leader with 30 years of experience in product development, compliance, and business operations. He has successfully managed projects from inception to commercial phase-out while ensuring adherence to FDA and EU regulations. An adept Agile practitioner, Dave promotes innovation and quality in regulated environments, and he also specializes in risk management for Class I, II, and III medical devices along with critical regulatory filings.